<DOC>
	<DOCNO>NCT02409823</DOCNO>
	<brief_summary>Antipsychotic drug characterize block dopaminergic D2 receptor . They find effective safe treatment schizophrenia , bipolar disorder , depressive episode associate bipolar disorder , psychotic symptom context Parkinson 's disease . Atypical antipsychotic low block potency D2 receptor , time interact serotoninergic , adrenergic histaminergic receptor , among others . Quetiapine extended-release clinical efficacy immediate-release formulation , reduces amount daily dos , possibly contribute increase treatment adherence . The purpose registry explore adherence treatment , occurrence adverse drug reaction clinical outcome sample patient treatment atypical antipsychotic several Central American country . For study , clinical data extract medical record 1000 patient schizophrenia , depressive disorder Parkinson 's Disease hallucination . Occurrence adverse drug reaction , namely weight gain , somnolence , extrapyramidal reaction symptom orthostatic hypotension ; adherence treatment ; change quality life clinical status assess first 8 week treatment .</brief_summary>
	<brief_title>Clinical Registry Patients Under Treatment With Atypical Antipsychotics</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Hallucinations</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>least 18 yearsold diagnosis schizophrenia , major depressive disorder , bipolar depressive disorder , parkinson 's disease hallucination patient receive antipsychotic usual treatment give inform consent participate treatment atypical antypsichotics disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>adverse drug reaction</keyword>
	<keyword>adherence treatment</keyword>
	<keyword>quality life</keyword>
	<keyword>clinical status</keyword>
</DOC>